Since 2021, our API manufacturing site in Celrà certified by the Japan Health Authority (PMDA)

31/05/2024

Since the end of 2021, our API manufacturing site in Celrà has been certified by the Japan Health Authority (PMDA) reinforcing our global commitment to meeting regulatory standards. The results were made possible by the #Medichemteam.

Our team provides expert #regulatory and #quality support throughout the registration and development process. With deep regulatory knowledge and a focus on quality, we help our #partners confidently navigate global market #complexities.

Partner with us to experience the difference expertise and dedication can make!

#genericmedicine #ActivePharmaceuticalIngredient #excellence